Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jun 29, 2016
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2016-06-27$2.08/sh−10,029$20,860→ 419,946 total
Footnotes (1)
- [F1]The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.